Evidence map›Paper›PMID 35057900›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2022

Development of a risk assessment profile tool to determine appropriate use of SARS-CoV-2 rapid antigen detection tests for different activities and events in Ireland, since October 2021.

Patrick Wg Mallon, Mary Horgan, Conor G McAloon, Peter D Lunn, Julian Little, Andrew Beck, Alexandria Bennett, Nicole Shaver, Aileen Conway, Rhea O'Regan and 3 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Patrick Wg MallonCentre for Experimental Pathogen Host Research (CEPHR), University College Dublin, Dublin, Ireland.
Mary HorganSchool of Medicine, University College Cork and Cork University Hospital, Cork, Ireland.
Conor G McAloonSchool of Veterinary Medicine, University College Dublin, Belfield, Dublin, Ireland.
Peter D LunnBehavioural Research Unit, Economic and Social Research Institute, Dublin, Ireland.
Julian LittleKnowledge Synthesis and Application Unit, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Andrew BeckKnowledge Synthesis and Application Unit, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Alexandria BennettKnowledge Synthesis and Application Unit, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Nicole ShaverKnowledge Synthesis and Application Unit, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
Aileen ConwayEvidence Synthesis Ireland, School of Nursing and Midwifery, National University of Ireland Galway, Galway, Ireland.
Rhea O'ReganEvidence Synthesis Ireland, School of Nursing and Midwifery, National University of Ireland Galway, Galway, Ireland.
Barbara WhelanEvidence Synthesis Ireland, School of Nursing and Midwifery, National University of Ireland Galway, Galway, Ireland.
Rapid Testing Expert Advisory Group, IrelandThe members of the RTEAG who were involved in writing this paper are listed under Investigators.
Members of the Rapid Testing Expert Advisory Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe the development of a risk assessment profile tool that incorporates data from multiple domains to help determine activities and events where rapid antigen detection tests (Ag-RDT) could be used to screen asymptomatic individuals to identify infectious cases as an additional mitigation measure to reduce transmission of SARS-CoV-2. The tool aims to stratify, in real time, the overall risk of SARS-CoV-2 transmission associated with common activities and events, and this can be matched to an appropriate Ag-RDT testing protocol.

Indexed as

COVID-19SARS-CoV-2Antigens, ViralHumansIrelandRisk AssessmentSensitivity and SpecificityAntigens, ViralAg-RDTCovid-19IrelandRADTrapid antigen detection testrisk assessmentSARS-CoV-2

Identifiers

PMID35057900
PMCPMC8804664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.